Pieris Pharmaceuticals Inc PIRS
$13.60
-2.53
(-15.69%)
Valuation
- Market cap
- 17,955,000
- Revenue TTM
- $42,810,000
- Net income TTM
- $-24,540,000
- P/E (trailing)
- 0.00
- P/E (forward)
- —
- Profit margin
- -57.32%
- Debt to equity
- 0.00
Trading
- Volume
- 51,700
- Avg volume
- 23,120
- Day's range
- $13.26 – $15.35
- Shares out
- 1,320,000
- Stochastic %K
- 8%
- Beta
- 0.61
- Analysts
- —
- Price target
- $560.00
Latest news
No headlines yet.
